Adicet Bio, Inc. Interest and Other Income
Adicet Bio, Inc. (ACET) reported Interest and Other Income of $1.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-05
- Adicet Bio, Inc. interest and other income for the quarter ending 2026-06-30 was $1.17M, a 16.45% decline year-over-year.
- Adicet Bio, Inc. interest and other income for the quarter ending 2026-03-31 was $1.34M, a 20.26% decline year-over-year.
- Adicet Bio, Inc. interest and other income for the quarter ending 2025-12-31 was $1.52M, a 26.27% decline year-over-year.
- Adicet Bio, Inc. interest and other income for the quarter ending 2025-09-30 was $1.17M, a 57.07% decline year-over-year.
- Adicet Bio, Inc. interest and other income for fiscal 2025 was $5.78M, a 46.08% decline from fiscal 2024.
- Adicet Bio, Inc. interest and other income for fiscal 2024 was $10.71M, a 7.38% increase from fiscal 2023.
- Adicet Bio, Inc. interest and other income for fiscal 2023 was $9.98M, a 165.37% increase from fiscal 2022.
- Adicet Bio, Inc. interest and other income for fiscal 2022 was $3.76M, a 4031.87% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.17M 10-Q · filed 2026-08-05 | $2.51M 10-Q · filed 2026-08-05 | $4.03M derived: sum of 3 quarters · filed 2026-08-05 | $5.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.34M 10-Q · filed 2026-05-13 | $2.87M derived: sum of 2 quarters · filed 2026-05-13 | $4.04M derived: sum of 3 quarters · filed 2026-05-13 | $5.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.70M derived: sum of 2 quarters · filed 2026-03-12 | $4.09M derived: sum of 3 quarters · filed 2026-08-05 | $5.78M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.17M 10-Q · filed 2025-11-05 | $2.57M derived: sum of 2 quarters · filed 2026-08-05 | $4.25M 10-Q · filed 2025-11-05 | $6.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.40M 10-Q · filed 2026-08-05 | $3.08M 10-Q · filed 2026-08-05 | $5.15M derived: sum of 3 quarters · filed 2026-08-05 | $7.88M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.68M 10-Q · filed 2026-05-13 | $3.75M derived: sum of 2 quarters · filed 2026-05-13 | $6.48M derived: sum of 3 quarters · filed 2026-05-13 | $9.48M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $4.80M derived: sum of 2 quarters · filed 2026-03-12 | $7.80M derived: sum of 3 quarters · filed 2026-03-12 | $10.71M 10-K · filed 2026-03-12 |
| 2024-09-30 | $2.73M 10-Q · filed 2025-11-05 | $5.73M derived: sum of 2 quarters · filed 2025-11-05 | $8.65M 10-Q · filed 2025-11-05 | $10.82M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $3.00M 10-Q · filed 2025-08-07 | $5.92M 10-Q · filed 2025-08-07 | $8.10M derived: sum of 3 quarters · filed 2025-08-07 | $10.62M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.92M 10-Q · filed 2025-05-06 | $5.10M derived: sum of 2 quarters · filed 2025-05-06 | $7.62M derived: sum of 3 quarters · filed 2025-05-06 | $10.23M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $4.70M derived: sum of 2 quarters · filed 2025-03-06 | $7.31M derived: sum of 3 quarters · filed 2025-03-06 | $9.98M 10-K · filed 2025-03-06 |
| 2023-09-30 | $2.52M 10-Q · filed 2024-11-06 | $5.13M derived: sum of 2 quarters · filed 2024-11-06 | $7.80M 10-Q · filed 2024-11-06 | $9.98M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $2.62M 10-Q · filed 2024-08-13 | $5.28M 10-Q · filed 2024-08-13 | $7.46M derived: sum of 3 quarters · filed 2024-08-13 | $8.68M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.67M 10-Q · filed 2024-05-14 | $4.84M derived: sum of 2 quarters · filed 2024-05-14 | $6.07M derived: sum of 3 quarters · filed 2024-05-14 | $6.39M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $3.40M derived: sum of 2 quarters · filed 2024-03-19 | $3.73M derived: sum of 3 quarters · filed 2024-03-19 | $3.76M 10-K · filed 2024-03-19 |
| 2022-09-30 | $1.22M 10-Q · filed 2023-11-08 | $1.55M derived: sum of 2 quarters · filed 2023-11-08 | $1.58M 10-Q · filed 2023-11-08 | $1.62M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $325.00K 10-Q · filed 2023-08-09 | $357.00K 10-Q · filed 2023-08-09 | $394.00K derived: sum of 3 quarters · filed 2023-08-09 | $398.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $32.00K 10-Q · filed 2023-05-09 | $69.00K derived: sum of 2 quarters · filed 2023-05-09 | $73.00K derived: sum of 3 quarters · filed 2023-05-09 | $82.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $41.00K derived: sum of 2 quarters · filed 2023-03-15 | $50.00K derived: sum of 3 quarters · filed 2023-03-15 | $91.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $4.00K 10-Q · filed 2022-11-08 | $13.00K derived: sum of 2 quarters · filed 2022-11-08 | $54.00K 10-Q · filed 2022-11-08 | $135.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $9.00K 10-Q · filed 2022-08-10 | $50.00K 10-Q · filed 2022-08-10 | $131.00K derived: sum of 3 quarters · filed 2022-08-10 | $284.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $41.00K 10-Q · filed 2022-05-12 | $122.00K derived: sum of 2 quarters · filed 2022-05-12 | $275.00K derived: sum of 3 quarters · filed 2022-05-12 | $504.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $234.00K derived: sum of 2 quarters · filed 2022-03-15 | $463.00K derived: sum of 3 quarters · filed 2022-03-15 | $785.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $153.00K 10-Q · filed 2021-11-10 | $382.00K derived: sum of 2 quarters · filed 2021-11-10 | $704.00K 10-Q · filed 2021-11-10 | $1.08M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $229.00K 10-Q · filed 2021-08-12 | $551.00K 10-Q · filed 2021-08-12 | $928.00K derived: sum of 3 quarters · filed 2021-08-12 | $1.20M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $322.00K 10-Q · filed 2021-05-17 | $699.00K derived: sum of 2 quarters · filed 2021-05-17 | $975.00K derived: sum of 3 quarters · filed 2021-05-17 | |
| 2019-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $653.00K derived: sum of 2 quarters · filed 2021-03-12 | $938.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $276.00K 10-Q · filed 2020-11-05 | $561.00K 10-Q · filed 2020-11-05 | ||
| 2018-12-31 | $543.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |